Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19?

Antibodies are made by the body as a defence against disease. However, they can also be produced in a laboratory from cells taken from people who have recovered from a disease.

Matéria original

Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19?

Discovery of novel inhibitors of SARS-CoV-2 main protease

Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect

Discovery of novel inhibitors of SARS-CoV-2 main protease￼

Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect￼￼

Discovery of novel inhibitors of SARS-CoV-2 main protease

Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect